Craig A Collard
CIK 1363558 · Chief Executive Officer · last filed 2026-08-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$286.9K
Companies
5
Total Filings
61
Lifetime Open-Market Net
-$17.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HRTX | Chief Executive Officer | 856,492 | $0.34 | $286.9K | $138.0K | 26 | 2026-08-03 |
| OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Director | 0 | $20.65 | $0 | $689.0K | 11 | 2023-03-03 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $310.9K | 4 | 2022-07-01 |
| CORNERSTONE THERAPEUTICS INC (CRTX) Delisted | Chief Executive Officer | 0 | $1.95 | $0 | -$18.22M | 9 | 2014-02-04 |
| CORNERSTONE THERAPEUTICS INC (CRTXD) Delisted | President and CEO | 3,202,225 | — | — | $0 | 1 | 2008-11-04 |
Recent Filings · Page 2 of 7
61 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-21 | HRTX | Exer (M) | +13,797 | $0 | EDGAR |
| 2025-08-04 | HRTX | Exer (M) | +34,789 | $0 | EDGAR |
| 2025-07-22 | HRTX | Exer (M) | +13,797 | $0 | EDGAR |
| 2025-06-25 | — | Grant (A) | +433,653 | $0 | |
| 2025-05-02 | HRTX | Exer (M) | +34,789 | $0 | EDGAR |
| 2025-04-22 | HRTX | Exer (M) | +13,796 | $0 | EDGAR |
| 2025-04-03 | HRTX | Exer (M) | +62,500 | $0 | EDGAR |
| 2025-03-26 | — | Tax (F) | −2,258 | -$1.0K | |
| 2025-02-04 | HRTX | Grant (A) | — | $0 | EDGAR |
| 2025-01-22 | HRTX | Exer (M) | +13,797 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.